Browsing by Author Fernández-Ruiz, Javier

Showing results 1 to 13 of 13
TitleAuthor(s)???itemlist.dc.contributor.advisor??????itemlist.dc.contributor.editor??????itemlist.dc.contributor.titulacion???Issue Date???itemlist.dc.identifier.doi??????itemlist.dc.source??????itemlist.dc.description.sjr??????itemlist.dc.description.sjrq??????itemlist.dc.description.jcr??????itemlist.dc.description.jcrq???TypePreview
Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's diseaseGonzález, Sara; Scorticati, Camila; García-Arencibia, Moisés ; Miguel, Rosario de; Ramos, José A., et al200610.1016/j.brainres.2005.12.014Brain Research[ISSN 0006-8993],v. 1073-1074, p. 209-2192,341Q3Artículo
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent propertiesGarcía-Arencibia, Moisés ; González, Sara; de Lago, Eva; Ramos, José A.; Mechoulam, Raphael, et al200710.1016/j.brainres.2006.11.063Brain Research[ISSN 0006-8993],v. 1134, p. 162-1702,218Q3Artículo
Cannabinoids and neuroprotection in Basal ganglia disordersSagredo, Onintza; Garcia-Arencibia, Moises ; De Lago, Eva; Finetti, Simone; Decio, Alessandra, et al200710.1007/s12035-007-0004-3Molecular Neurobiology[ISSN 0893-7648],v. 36 (1), p. 82-914,067Q1Reseña
Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned ratsGarcía-Arencibia, Moisés ; Ferraro, Luca; Tanganelli, Sergio; Fernández-Ruiz, Javier200810.1016/j.neulet.2008.04.041Neuroscience Letters[ISSN 0304-3940],v. 438, p. 10-132,2Q3Artículo
Role of CB2 receptors in neuroprotective effects of cannabinoidsFernández-Ruiz, Javier; Pazos, María Ruth; García-Arencibia, Moisés ; Sagredo, Onintza; Ramos, José A.200810.1016/j.mce.2008.01.001Molecular and Cellular Endocrinology [ISSN 0303-7207], v. 286 (1-2), p. S91-S963,611Q2Artículo
Cannabinoids and Parkinson's DiseaseGarcía-Arencibia, Moisés ; García, Concepción; Fernández-Ruiz, Javier200910.2174/187152709789824642WOS:000272738000004CNS and Neurological Disorders - Drug Targets [ISSN 1871-5273], v. 8, p. 432-4393,571Q1Artículo
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegenerationGispert, Suzana; Ricciardi, Filomena; Kurz, Alexander; Azizov, Mekhman; Hoepken, Hans Hermann, et al200910.1371/journal.pone.0005777WOS:000266624300013Plos One [ISSN 1932-6203], v. 4 (6)4,351Q1ArtículoParkinson Phenotype in Aged PINK1 Deficient Mice.pdf.jpg
Cannabinoid CB<inf>1</inf> receptors are early DownRegulated followed by a further UpRegulation in the basal Ganglia of mice with deletion of specific park genesGarcía-Arencibia, Moisés ; García, Concepción ; Kurz, Alexander; Rodríguez-Navarro, José A.; Gispert-Sánchez, Suzana, et al200910.1007/978-3-211-92660-4-22Journal of Neural Transmission, Supplementa [ISSN 0303-6995], p. 269-2752,525Q3Artículo
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old miceKurz, Alexander; Double, Kay L.; Lastres-Becker, Isabel; Tozzi, Alessandro; Tantucci, Michela, et al201010.1371/journal.pone.0011464WOS:000279589300011Plos One [ISSN 1932-6203], v. 5 (7)4,411Q1ArtículoA53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling.pdf.jpg
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's diseaseGonzález-Naranjo, Pedro; Pérez-Macias, Natalia; Campillo, Nuria E.; Pérez López, Concepción ; Arán, Vicente J., et al201410.1016/j.ejmech.2013.11.026WOS:000331916500007European Journal Of Medicinal Chemistry [ISSN 0223-5234], v. 73, p. 56-721,074Q13,447Q1Artículo
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB(2) receptor antagonistsRagusa, Giulio; Gómez-Cañas, María; Morales, Paula; Hurst, Dow P.; Deligia, Francesco, et al201510.1016/j.ejmech.2015.06.057European Journal Of Medicinal Chemistry[ISSN 0223-5234],v. 101, p. 651-6671,152Q13,902Q1Artículo
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB<inf>2</inf>receptor ligands with antagonist/inverse agonist propertiesDeiana, Valeria; Gómez-Cañas, María; Pazos, M. Ruth; Fernández-Ruiz, Javier; Asproni, Battistina, et al201610.1016/j.ejmech.2016.02.005European Journal of Medicinal Chemistry [ISSN 0223-5234], v. 112, p. 66-801,272Q14,519Q1Artículo
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: Possible involvement of different binding sites at the PPARγ receptorGarcía, Concepción; Gómez-Cañas, María; Burgaz, Sonia; Palomares, Belén; Gómez-Gálvez, Yolanda, et al201810.1186/s12974-018-1060-5Journal of Neuroinflammation [1742-2094], v. 15, article 192,299Q15,7Q1ArtículoBenefits_VCE-003.2.pdf.jpg